• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.实用考量与建议:主方案框架(篮子试验、伞式试验、平台试验)
Ther Innov Regul Sci. 2021 Nov;55(6):1145-1154. doi: 10.1007/s43441-021-00315-7. Epub 2021 Jun 23.
2
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.系统评价篮子试验、伞式试验和平台试验:主方案的全景分析。
Trials. 2019 Sep 18;20(1):572. doi: 10.1186/s13063-019-3664-1.
3
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.主方案临床试验设计的演变:一项系统文献综述
Clin Ther. 2020 Jul;42(7):1330-1360. doi: 10.1016/j.clinthera.2020.05.010. Epub 2020 Jul 1.
4
Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.掌握炎症与免疫学领域的主方案及其他创新试验设计,以加速临床药物研发。
Drug Discov Today. 2024 May;29(5):103948. doi: 10.1016/j.drudis.2024.103948. Epub 2024 Mar 8.
5
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.晚期临床试验平台方案实施指导:来自英国经验丰富的临床试验机构的经验教训。
Trials. 2022 Sep 6;23(1):757. doi: 10.1186/s13063-022-06680-4.
6
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.当前确认性篮子、伞式和平台试验规划的统计考虑因素和监管观点。
Clin Pharmacol Ther. 2020 May;107(5):1059-1067. doi: 10.1002/cpt.1804. Epub 2020 Apr 1.
7
[Application of umbrella design and basket design in evidence-based research for traditional Chinese medicine].[伞形设计与篮形设计在中医药循证研究中的应用]
Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(8):2010-2015. doi: 10.19540/j.cnki.cjcmm.20210204.501.
8
Challenges with Novel Clinical Trial Designs: Master Protocols.新型临床试验设计面临的挑战:主方案。
Clin Cancer Res. 2019 Apr 1;25(7):2049-2057. doi: 10.1158/1078-0432.CCR-18-3544. Epub 2019 Jan 29.
9
Master protocol trials in oncology: Review and new trial designs.肿瘤学中的主方案试验:综述与新试验设计
Contemp Clin Trials Commun. 2018 Aug 24;12:1-8. doi: 10.1016/j.conctc.2018.08.009. eCollection 2018 Dec.
10
Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.精准医学中的新型研究设计——篮子、伞式和平台试验。
Curr Rev Clin Exp Pharmacol. 2022;17(2):114-121. doi: 10.2174/1574884716666210316114157.

引用本文的文献

1
Glycaemic control in labour with diabetes: GILD, a scoping study.糖尿病产妇分娩期间的血糖控制:GILD,一项范围界定研究。
Health Technol Assess. 2025 Aug;29(41):1-150. doi: 10.3310/KHGD2761.
2
Master protocols in low- and middle-income countries: a review of current use, limitations and opportunities for precision medicine.低收入和中等收入国家的主方案:精准医学的当前应用、局限性及机遇综述
BMJ Glob Health. 2025 Jul 25;10(7):e018561. doi: 10.1136/bmjgh-2024-018561.
3
Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches.肝细胞癌的抗体治疗:当前及新兴方法综述
Front Immunol. 2025 Jun 20;16:1533874. doi: 10.3389/fimmu.2025.1533874. eCollection 2025.
4
From geroscience to precision geromedicine: Understanding and managing aging.从老年科学到精准老年医学:理解与应对衰老
Cell. 2025 Apr 17;188(8):2043-2062. doi: 10.1016/j.cell.2025.03.011.
5
An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in persons with HIV.一项高效的疫苗临床试验:美国国立过敏和传染病研究所艾滋病临床试验组A5379号针对HIV感染者的乙肝疫苗试验
Vaccine. 2025 May 10;55:127028. doi: 10.1016/j.vaccine.2025.127028. Epub 2025 Mar 26.
6
Factors involving in healthcare professionals' decision-making process regarding the use of restrictive care practices in adult mental health inpatient units: A protocol for an umbrella review.涉及医疗保健专业人员在成人心理健康住院单元使用限制性护理措施决策过程的因素:一项系统综述方案
PLoS One. 2025 Feb 24;20(2):e0319228. doi: 10.1371/journal.pone.0319228. eCollection 2025.
7
Molecular and modular intricacies of precision oncology.精准肿瘤学的分子和模块复杂性。
Front Immunol. 2024 Oct 23;15:1476494. doi: 10.3389/fimmu.2024.1476494. eCollection 2024.
8
Types and progress of clinical trial design for breast cancer: a narrative review.乳腺癌临床试验设计的类型与进展:一项叙述性综述
Transl Breast Cancer Res. 2023 Jul 30;4:20. doi: 10.21037/tbcr-23-22. eCollection 2023.
9
Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics.解锁潜力:儿科主方案的系统评价。
Ther Innov Regul Sci. 2024 Jul;58(4):634-644. doi: 10.1007/s43441-024-00656-z. Epub 2024 Apr 23.
10
Pediatric oncology drug development and dosage optimization.儿科肿瘤学药物研发与剂量优化
Front Oncol. 2024 Jan 29;13:1235947. doi: 10.3389/fonc.2023.1235947. eCollection 2023.

本文引用的文献

1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.仑伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌。
N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13.
2
Multiplicity issues for platform trials with a shared control arm.具有共享对照臂的平台试验的多重性问题。
J Biopharm Stat. 2020 Nov 1;30(6):1077-1090. doi: 10.1080/10543406.2020.1821703. Epub 2020 Sep 29.
3
Flexible Bayesian subgroup analysis in early and confirmatory trials.灵活的贝叶斯亚组分析在早期和确证性试验中。
Contemp Clin Trials. 2020 Nov;98:106149. doi: 10.1016/j.cct.2020.106149. Epub 2020 Sep 15.
4
Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate.多臂临床试验中 I 类错误率的控制:假发现率的一个案例。
Pharm Stat. 2021 Jan;20(1):109-116. doi: 10.1002/pst.2059. Epub 2020 Aug 12.
5
Commentary on Parker and Weir.关于帕克和韦尔的评论
Clin Trials. 2020 Oct;17(5):567-569. doi: 10.1177/1740774520941420. Epub 2020 Jul 15.
6
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification.多臂试验中不同处理组不进行多重检验:原理与理由。
Clin Trials. 2020 Oct;17(5):562-566. doi: 10.1177/1740774520941419. Epub 2020 Jul 15.
7
Including non-concurrent control patients in the analysis of platform trials: is it worth it?在平台试验分析中纳入非同期对照患者:值得吗?
BMC Med Res Methodol. 2020 Jun 24;20(1):165. doi: 10.1186/s12874-020-01043-6.
8
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata.贝叶斯半参数设计(BSD)用于具有多个层的自适应剂量发现。
J Biopharm Stat. 2020 Sep 2;30(5):806-820. doi: 10.1080/10543406.2020.1730870. Epub 2020 Mar 4.
9
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.当前确认性篮子、伞式和平台试验规划的统计考虑因素和监管观点。
Clin Pharmacol Ther. 2020 May;107(5):1059-1067. doi: 10.1002/cpt.1804. Epub 2020 Apr 1.
10
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study.帕博利珠单抗治疗既往治疗的晚期神经内分泌肿瘤的疗效和安全性:来自 II 期 KEYNOTE-158 研究的结果。
Clin Cancer Res. 2020 May 1;26(9):2124-2130. doi: 10.1158/1078-0432.CCR-19-3014. Epub 2020 Jan 24.

实用考量与建议:主方案框架(篮子试验、伞式试验、平台试验)

Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.

机构信息

Analytics and Data Sciences, Biogen Inc, 300 Binney St, Cambridge, MA, 02142, USA.

Biostatistics and Research Decision Sciences, Merck & Co., Inc, Kenilworth, NJ, 07033, USA.

出版信息

Ther Innov Regul Sci. 2021 Nov;55(6):1145-1154. doi: 10.1007/s43441-021-00315-7. Epub 2021 Jun 23.

DOI:10.1007/s43441-021-00315-7
PMID:34160785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8220876/
Abstract

Master protocol, categorized as basket trial, umbrella trial or platform trial, is an innovative clinical trial framework that aims to expedite clinical drug development, enhance trial efficiency, and eventually bring medicines to patients faster. Despite a clear uptake on the advantages in the concepts and designs, master protocols are still yet to be widely used. Part of that may be due to the fact that the master protocol framework comes with the need for new statistical designs and considerations for analyses and operational challenges. In this article, we provide an overview of the master protocol framework, unify the definitions with some examples, review the statistical methods for the designs and analyses, and focus our discussions on some practical considerations and recommendations of master protocols to help practitioners better design and implement such studies.

摘要

主方案(Master protocol),也被归类为篮子试验、伞式试验或平台试验,是一种创新的临床试验框架,旨在加速临床药物开发、提高试验效率,并最终更快地为患者带来药物。尽管在概念和设计方面优势明显,但主方案仍未得到广泛应用。部分原因可能是主方案框架需要新的统计设计和分析考虑,以及操作挑战。本文提供了主方案框架的概述,用一些例子统一了定义,回顾了设计和分析的统计方法,并重点讨论了主方案的一些实际考虑因素和建议,以帮助实践者更好地设计和实施此类研究。